NOVA LEAP HEALTH CORP (NLH.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:NLH - CA66980G1090 - Common Stock
0.29 CAD
-0.01 (-3.33%)
We assign a fundamental rating of 4 out of 10 to NLH. NLH was compared to 13 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of NLH get a neutral evaluation. Nothing too spectacular is happening here. NLH has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
NLH had positive earnings in the past year.
In the past year NLH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NLH reported negative net income in multiple years.
NLH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
NLH has a better Return On Assets (3.18%) than 73.33% of its industry peers.
NLH has a better Return On Equity (4.00%) than 73.33% of its industry peers.
NLH has a Return On Invested Capital of 4.16%. This is in the better half of the industry: NLH outperforms 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.18% | ||
| ROE | 4% | ||
| ROIC | 4.16% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of NLH (2.50%) is better than 66.67% of its industry peers.
In the last couple of years the Profit Margin of NLH has declined.
Looking at the Operating Margin, with a value of 3.56%, NLH is in line with its industry, outperforming 60.00% of the companies in the same industry.
NLH's Gross Margin of 39.51% is in line compared to the rest of the industry. NLH outperforms 46.67% of its industry peers.
In the last couple of years the Gross Margin of NLH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.56% | ||
| PM (TTM) | 2.5% | ||
| GM | 39.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NLH is destroying value.
NLH has more shares outstanding than it did 1 year ago.
NLH has more shares outstanding than it did 5 years ago.
NLH has a worse debt/assets ratio than last year.
2.2 Solvency
NLH has an Altman-Z score of 3.64. This indicates that NLH is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.64, NLH belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
The Debt to FCF ratio of NLH is 1.89, which is an excellent value as it means it would take NLH, only 1.89 years of fcf income to pay off all of its debts.
NLH's Debt to FCF ratio of 1.89 is amongst the best of the industry. NLH outperforms 100.00% of its industry peers.
NLH has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
NLH has a Debt to Equity ratio of 0.04. This is amongst the best in the industry. NLH outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 1.89 | ||
| Altman-Z | 3.64 |
ROIC/WACC0.53
WACC7.83%
2.3 Liquidity
NLH has a Current Ratio of 0.93. This is a bad value and indicates that NLH is not financially healthy enough and could expect problems in meeting its short term obligations.
NLH's Current ratio of 0.93 is fine compared to the rest of the industry. NLH outperforms 80.00% of its industry peers.
A Quick Ratio of 0.93 indicates that NLH may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.93, NLH is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 260.00% over the past year.
The earnings per share for NLH have been decreasing by -11.19% on average. This is quite bad
The Revenue has grown by 16.47% in the past year. This is quite good.
Measured over the past years, NLH shows a quite strong growth in Revenue. The Revenue has been growing by 8.16% on average per year.
EPS 1Y (TTM)260%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%304.17%
Revenue 1Y (TTM)16.47%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%29%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 29.00, NLH can be considered very expensive at the moment.
Based on the Price/Earnings ratio, NLH is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.92, NLH is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NLH is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
73.33% of the companies in the same industry are more expensive than NLH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.61 | ||
| EV/EBITDA | 10.76 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NLH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX-V:NLH (12/24/2025, 7:00:00 PM)
0.29
-0.01 (-3.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners18.98%
Ins Owner ChangeN/A
Market Cap25.32M
Revenue(TTM)29.96M
Net Income(TTM)750.20K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29 | ||
| Fwd PE | N/A | ||
| P/S | 0.62 | ||
| P/FCF | 11.61 | ||
| P/OCF | 11.43 | ||
| P/B | 0.99 | ||
| P/tB | 16.98 | ||
| EV/EBITDA | 10.76 |
EPS(TTM)0.01
EY3.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY8.61%
OCF(TTM)0.03
OCFY8.75%
SpS0.47
BVpS0.29
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.26
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.18% | ||
| ROE | 4% | ||
| ROCE | 5.47% | ||
| ROIC | 4.16% | ||
| ROICexc | 4.52% | ||
| ROICexgc | 314.27% | ||
| OM | 3.56% | ||
| PM (TTM) | 2.5% | ||
| GM | 39.51% | ||
| FCFM | 5.32% |
ROA(3y)-0.79%
ROA(5y)2.27%
ROE(3y)-0.91%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.52%
PM growth 5YN/A
GM growth 3Y4.24%
GM growth 5Y2.71%
F-Score7
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 1.89 | ||
| Debt/EBITDA | 0.4 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 5 | ||
| Cash Conversion | 87.34% | ||
| Profit Quality | 212.38% | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.93 | ||
| Altman-Z | 3.64 |
F-Score7
WACC7.83%
ROIC/WACC0.53
Cap/Depr(3y)4.23%
Cap/Depr(5y)2.79%
Cap/Sales(3y)0.15%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260%
EPS 3Y-11.19%
EPS 5YN/A
EPS Q2Q%304.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.47%
Revenue growth 3Y6.58%
Revenue growth 5Y8.16%
Sales Q2Q%29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.32%
FCF growth 3Y-14.49%
FCF growth 5Y17.9%
OCF growth 1Y15.07%
OCF growth 3Y-13.97%
OCF growth 5Y17.73%
NOVA LEAP HEALTH CORP / NLH.CA FAQ
Can you provide the ChartMill fundamental rating for NOVA LEAP HEALTH CORP?
ChartMill assigns a fundamental rating of 4 / 10 to NLH.CA.
What is the valuation status for NLH stock?
ChartMill assigns a valuation rating of 3 / 10 to NOVA LEAP HEALTH CORP (NLH.CA). This can be considered as Overvalued.
How profitable is NOVA LEAP HEALTH CORP (NLH.CA) stock?
NOVA LEAP HEALTH CORP (NLH.CA) has a profitability rating of 5 / 10.
What is the financial health of NOVA LEAP HEALTH CORP (NLH.CA) stock?
The financial health rating of NOVA LEAP HEALTH CORP (NLH.CA) is 6 / 10.